Effectiveness of probiotic therapy for gastrointestinal forms of food allergy in children

O.M. Okhotnikova, Yu.R. Chernysh

Abstract


Background. Intestinal microbiota is involved in the development of oral tolerance. Therefore, there is interest in using probiotics that will contribute to colonization of the intestine, as well as to the development of intestinal homeostasis. There is also a need for studies on the effectiveness of probiotics for the prevention and treatment of allergic diseases in children. The purpose of the study was to evaluate the effectiveness of using biopreparation created on the basis of the spore-forming microorganism Bacillus subtilis in the comprehensive therapy of children with gastrointestinal symptoms of food allergy. Materials and methods. We examined 34 children aged 3.5 to 12 years with food allergies with gastrointestinal complaints. The main group included 18 children, the comparison group consisted of 16 patients. Children of the main group in addition to basic therapy received probiotic on the basis of Bacillus subtilis (1 dose 2 times a day for 20 days). The effectiveness of therapy was assessed by the rate and completeness of reduction of gastrointestinal symptoms and manifestations of comorbid allergic pathology. Results. In patients of the main group, the reduction of gastrointestinal symptoms and symptoms of comorbid allergic pathology was faster. A gradual decrease in the level of specific IgE to food and inhalant allergens by 25–30 % was noted after 10 days of using comprehensive treatment, and by 35–40 % — in 21 days after taking the probiotic based on Bacillus subtilis. All children had changes in the bacteriological examination of the stool (the lack of bifido- and lactobacilli, an increase in the number and changes in the species ratio of the opportunistic flora). Normalization of the intestinal microbiocenosis was noted in 78 % of cases after repeated bacteriological study of stool in children of the main group. After taking the probiotic based on Bacillus subtilis, there were no complications or side effects in all patients, while episodes of abdominal pain and stool disorders were observed in children of the comparison group. There was a moderate improvement in the clinical symptoms of comorbid allergic pathology (allergic rhinitis, atopic dermatitis, bronchial asthma) during the 3-week course of using probiotic on the basis of Bacillus subtilis. Conclusions. The administration of the probiotic based on Bacillus subtilis in the comprehensive therapy of children with gastrointestinal form of food allergy promotes rapid regression of gastrointestinal manifestations and improves general condition of patients.

Keywords


children; Bacillus subtilis; gastrointestinal food ­allergy

References


Prescott S, Allen KJ. Food allergy: riding the second wave of allergy epidemic. Pediatr. AllergyImmunol. 2011;22(2):156-60. doi: 10.1111/j.1399-3038.2011.01145.x.

Boyce JA, Assa'ad A, Burks AW, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010;126(60):S1-S58. doi: 10.1016%2Fj.jaci.2010.10.007.

Morita H, Nomura I, Matsuda A, et al. Gastrointestinal Food Allergy in Infants. Allergology International. 2013;62(3):297-307. doi: 10.2332/allergolint.13-RA-0542.

Prescott SL, Pawankar R, Allen KJ, et al. A global survey of changing patterns of food allergy burden in children. World Allergy Organ J. 2013;6:21. doi: 10.1186/1939-4551-6-21.

Castellazzi AM, Valsecchi C, Caimmi S, et al. Probiotics and food allergy. Ital J Pediatr. 2013;39:47. doi: 10.1186%2F1824-7288-39-47.

Dahan S, Roth-Walter F, Arnaboldi P, et al. Epithelia: lymphocyte interactions in the gut. Immunol Rev. 2007;215:243-53. doi: 10.1111/j.1600-065X.2006.00484.x.

Round JL, Mazmanian SK. The gut microbiota shapes intestina limmune responses during health and disease. Nat Rev Immunol. 2009;9(5):313-23. doi: 10.1038%2Fnri2515.

Holt PG, Strickland DH. Soothing signals: transplacental transmission of resistance to asthma and allergy. J Exp Med. 2009;206:2861-4. doi: 10.1084%2Fjem.20092469.

Caffarelli C, Baldi F, Bendandi B, et al. EWGPAG. Cow’s milk protein allergy in children: a practical guide. Ital J Pediatr. 2010;36:5. doi: 10.1186/1824-7288-36-5.

EFSA. EFSA Scientific Colloquium Summary Report. QPS: qualified presumption of safety of microorganisms in food and feed vi aCarlo Magno 1A-43126 Parma, Italy: EFSA (Autorità Europea Sicurezza Alimentare); 2004. Available from: https://www.efsa.europa.eu/en/supporting/pub/109e

Iannitti T, Palmieri В. Therapeutical use of probiotic formulations in clinical practice. ClinNutr. 2010;29(6):701-25. doi: 10.1016/j.clnu.2010.05.004.

Niankovsky SL. Ivakhnenko OS. Role and place of probiotics in prevention and treatment of allergy in children. Ditjachii Lіkar. 2013;4(25):24-31. (In Ukrainian).

Ann AT, Susan V. Gut Microbiota and Allergic Disease. New Insights Soc. 2016 Mar; 13(Suppl 1):51-4. doi: 10.1513/AnnalsATS.201507-451MG.

Lezhenko GO, Pashkova OYe. Place of probiotics in therapy and prevention of secondary acetonimic syndrome development. Zdorov'ye. 2015;3(63):31-4. (In Ukrainian).

Savustyanenko AV. Mechanisms of action of probiotics based on Bacillus subtilis. Aktual'naya Infektologiya. 2016;2(11):35-44. (In Russian). doi.org/10.22141/2312-413x.2.11.2016.77529.




DOI: https://doi.org/10.22141/2224-0551.12.5.2017.109271

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 CHILD`S HEALTH

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2018

 

   Seo анализ сайта